08:25 AM EDT, 08/05/2025 (MT Newswires) -- Ocular Therapeutix ( OCUL ) reported a Q2 loss Tuesday of $0.39 per diluted share, compared with a loss of $0.26 a year earlier.

Analysts polled by FactSet expected a loss of $0.35.

Total revenue for the quarter ended June 30 was $13.5 million, down from $16.4 million a year earlier.

Analysts surveyed by FactSet expected $13.6 million.

Shares of the company fell more than 4% in Tuesday's premarket activity.

Price: 11.75, Change: -0.60, Percent Change: -4.86